- Home
- RPRX vs TRMB Comparison
RPRX vs TRMB Comparison
Compare RPRX & TRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | TRMB |
|---|---|---|
| Founded | 1996 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 16.5B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RPRX | TRMB |
|---|---|---|
| Price | $46.19 | $66.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $47.75 | ★ $94.71 |
| AVG Volume (30 Days) | ★ 3.1M | 1.8M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.78 | 1.76 |
| Revenue | $2,378,193,000.00 | ★ $3,798,700,000.00 |
| Revenue This Year | $38.30 | $9.94 |
| Revenue Next Year | $4.80 | $8.22 |
| P/E Ratio | ★ $26.22 | $38.42 |
| Revenue Growth | ★ 5.06 | 3.33 |
| 52 Week Low | $29.66 | $52.91 |
| 52 Week High | $47.86 | $87.50 |
Technical Indicators
Market Signals| Indicator | RPRX | TRMB |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 42.04 |
| Support Level | $35.32 | $63.52 |
| Resistance Level | $46.14 | $68.92 |
| Average True Range (ATR) | 0.90 | 1.96 |
| MACD | -0.19 | 0.22 |
| Stochastic Oscillator | 37.86 | 24.27 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TRMB Trimble Inc.
Trimble Inc is a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has three reportable segments: Architects, Engineers, Construction, and Owners (AECO). This segment provides software solutions that sell through a direct channel to customers in the construction industry. Field Systems. This segment provides hardware and associated software solutions that sell through dealer partner channels. Transportation and Logistics (T&L). This segment provides solutions for customers working in long-haul trucking and freight shipping markets.